Articles

Implantable drug-eluting devices (DEDs) have come a long way since 1938, when Finland approved a subcutaneously administered birth control device delivering levonorgestrel. Over their development history, the therapeutic performance and value of DEDs has evolved significantly, and recent innovation has...

Innovation is unarguably the essence of pharmaceutical discovery and development. Industry and academia have been working together for decades, but historically relationships did not extend far beyond the traditional exchange of funding and research. There is a risk, however,...

Antibodies are widely used in pre-clinical research to study proteins and their functions in biological pathways and diseased states. These tools, with their high specificity and sensitivity, help life science researchers to easily identify proteins of interest at various...

Preparing for Russia’s regulation requirements might seem like a mountain to climb, but it’s a necessary journey for companies that want to remain in or enter the 10th largest pharmaceutical market in the world. With the global market expected to...

Current data collection practices in clinical research are facing many challenges. There is a broad recognition that issues prevail with the current clinical research data collection processes and systems. Industry leaders, such as Janet Woodcock, of the FDA's Centre for...

Being a life sciences researcher today involves being inundated with data from every direction. Every day, new studies are published, conferences held, and experiments conducted. Despite rumours the age of the ‘blockbuster’ drug might be over, we’re currently seeing record...

No matter if it is meeting the needs of a rapidly aging market, blocking drug counterfeiters or differentiating your pharmaceutical product in the market, a secondary packaging program is essential to achieve success. However, pharma and biotech companies tend...